Metropolis Healthcare Ltd - 542650 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2024 Metropolis Healthcare Ltd - 542650 - Closure of Trading Window
The trading window will be closed with effect from July 01, 2024 and shall remain closed up to 48 hours after the declaration of the Financial Results for the quarter ending June 30, 2024. Metropolis Healthcare Ltd - 542650 - Grant Of Restrictive Stock Units (Rsus) Under The Metropolis Healthcare Limited - Restrictive Stock Unit Plan, 2020 (MHL-RSU Plan, 2020)
The Nomination and Remuneration Committee of the Board of Directors of the Company vide circular resolution dated June 15, 2024, has approved grant of 58,000 RSUs under MHL-RSU Plan, 2020 to the eligible employee(s) of the Company. Metropolis Healthcare Ltd - 542650 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr Sushil Kanubhai Shah & PACs Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the officials of the Company will be meeting Investors on June 13, 2024. Metropolis Healthcare Ltd - 542650 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for the financial year ended March 31, 2024. Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the officials of the Company will be meeting Investors on June 05, 2024. Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of Q4 FY24 earnings conference call held on May 22, 2024.
Metropolis Healthcare to invest in new segments, plans expansion into underserved areas
Aligned with its expansion plans, Metropolis aims to boost its collection centre networks and enhance service standards, particularly in Tier II and III markets. Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30(6) of SEBI (LODR) Regulations, 2015, the Company will be meeting with investors as per the details attached herewith this letter.